HomeBusinessHealthcare Industry Stock NewsSarepta (SRPT) Soars on FDA Approval on Muscular Dystrophy Treatment

Sarepta (SRPT) Soars on FDA Approval on Muscular Dystrophy Treatment

Sarepta (SRPT) soars after the FDA approves expanded use of their Muscular Dystrophy treatment. Jenny Horne weighs in on this story. Tune in to find out more about the stock market today.

Morning Trade Live

21 Jun 2024

SHARE

ON AIR
6:00 pm
Fast Market
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
9:30 am
Market Overtime
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
4:30 pm
Market Overtime
REPLAY
5:00 pm
Trading 360
REPLAY
ON AIR
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor